Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/15/23 18:46 | 8/15/23 | ALT | Health | Drug | Pharmaceutical Preparations | Drutz David | MD | D | P | 1 | 2.88 | 0 | 0 | 1 | 30 | I | |||||||||||||||
3/27/23 17:17 | 3/23/23 | ALT | Health | Drug | Pharmaceutical Preparations | Drutz David | MD | D | P | 38 | 4.27 | 0 | 9 | 44 | 29 | I | |||||||||||||||
3/24/23 20:54 | 3/24/23 | ALT | Health | Drug | Pharmaceutical Preparations | Eisenstadt Richard I | MD | O | CFO | P | 43 | 4.31 | 0 | 10 | 83 | 22 | D | ||||||||||||||
3/23/23 20:28 | 3/23/23 | ALT | Health | Drug | Pharmaceutical Preparations | Harris Matthew Scott | MD | O | Chief Me | P | 42 | 4.22 | 0 | 10 | 43 | 33 | D | ||||||||||||||
6/16/22 21:27 | 6/15/22 | ALT | Health | Drug | Pharmaceutical Preparations | Drutz David | MD | D | P | 8 | 8.00 | 0 | 1 | 5 | 20 | D | |||||||||||||||
5/25/22 19:00 | 5/24/22 | ALT | Health | Drug | Pharmaceutical Preparations | Drutz David | MD | D | P | 5 | 4.50 | 0 | 1 | 7 | 19 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |